Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole

NCT02299687 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Stomach Ulcer

Interventions

DRUG: Omeprazole

Sponsor

Seoul National University Hospital